These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21968693)

  • 21. Role of APRIL (TNFSF13) polymorphisms in the susceptibility to systemic lupus erythematosus in Japanese.
    Kawasaki A; Tsuchiya N; Ohashi J; Murakami Y; Fukazawa T; Kusaoi M; Morimoto S; Matsuta K; Hashimoto H; Takasaki Y; Tokunaga K
    Rheumatology (Oxford); 2007 May; 46(5):776-82. PubMed ID: 17307753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum soluble TWEAK levels are decreased in treatment naive noncirrhotic chronic hepatitis B patients.
    Asil M; Dertli R
    Medicine (Baltimore); 2016 Sep; 95(37):e4763. PubMed ID: 27631226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.
    Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR
    Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus.
    Luo Q; Rao J; Zhang L; Fu B; Guo Y; Huang Z; Li J
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1298. PubMed ID: 32583611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Expression of tumor necrosis factor-alpha signaling adapter proteins in peripheral blood mononuclear cells from patients with systemic lupus erythematosus].
    Zhu LJ; Yang X; Chen WY; Li XY; Ji YL; Mao HP; Nie J; Yu XQ
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3102-6. PubMed ID: 18269865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the tumour necrosis factor-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor-inducible 14 (Fn14) axis in autoimmune thyroid disease.
    Peng S; Yu X; Zhao X; Wang X; Sun X; Han C; Shan Z; Li C; Teng W
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):783-790. PubMed ID: 28636775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expressions of the TNF-alpha signaling adapters in peripheral blood mononuclear cells (PBMCs) are correlated with disease activity in patients with systemic lupus erythematosus.
    Zhu L; Yang X; Chen W; Li X; Ji Y; Mao H; Nie J; Yu X
    Clin Rheumatol; 2007 Sep; 26(9):1481-9. PubMed ID: 17235653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.
    Li J; Xie H; Wen T; Liu H; Zhu W; Chen X
    J Rheumatol; 2010 Apr; 37(4):766-75. PubMed ID: 20110525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypermethylation of glucocorticoid receptor gene promoter results in glucocorticoid receptor gene low expression in peripheral blood mononuclear cells of patients with systemic lupus erythematosus.
    Chen H; Fan J; Shou Q; Zhang L; Ma H; Fan Y
    Rheumatol Int; 2015 Aug; 35(8):1335-42. PubMed ID: 25899090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Necrosis Factor-Like Weak Inducer of Apoptosis Activates Type I Interferon Signals in Lupus Nephritis.
    Xue L; Liu L; Huang J; Wen J; Yang R; Bo L; Tang M; Zhang Y; Liu Z
    Biomed Res Int; 2017; 2017():4927376. PubMed ID: 29333443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered mRNA expression levels of vaspin and adiponectin in peripheral blood mononuclear cells of systemic lupus erythematosus patients.
    Zhang TP; Zhao YL; Li XM; Wu CH; Pan HF; Ye DQ
    Clin Exp Rheumatol; 2019; 37(3):458-464. PubMed ID: 30183598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J; Doerner J; Weidenheim K; Xia Y; Stock A; Michaelson JS; Baruch K; Deczkowska A; Gulinello M; Schwartz M; Burkly LC; Putterman C
    J Autoimmun; 2015 Jun; 60():40-50. PubMed ID: 25911200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.
    Sourour SK; Aboelenein HR; Elemam NM; Abdelhamid AK; Salah S; Abdelaziz AI
    Int J Rheum Dis; 2017 Sep; 20(9):1237-1246. PubMed ID: 28523761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-C1q antibodies, sCD40L, TWEAK and CD4/CD8 ratio in systemic lupus erythematosus and their relations to disease activity and renal involvement.
    ElGendi SS; El-Sherif WT
    Egypt J Immunol; 2009; 16(1):135-48. PubMed ID: 20726330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased mRNA expression levels of DNA methyltransferases type 1 and 3A in systemic lupus erythematosus.
    Nawrocki MJ; Majewski D; Puszczewicz M; Jagodziński PP
    Rheumatol Int; 2017 May; 37(5):775-783. PubMed ID: 28349196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
    Minowa K; Amano H; Nakano S; Ando S; Watanabe T; Nakiri Y; Amano E; Tokano Y; Morimoto S; Takasaki Y
    Autoimmunity; 2011 Aug; 44(5):357-62. PubMed ID: 21320038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells and their molecular markers in peripheral blood of the patients with systemic lupus erythematosus.
    Hu S; Xiao W; Kong F; Ke D; Qin R; Su M
    J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):549-52. PubMed ID: 18846336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of IL-23 mRNA in Systemic Lupus Erythramtosus Patients: Relation with Disease Activity.
    ElGlil RR; Emam SM; Hashaad NI
    Egypt J Immunol; 2015 Jun; 22(2):9-21. PubMed ID: 28502140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of tumour necrosis factor-related weak inducer of apoptosis/fibroblast growth factor-inducible 14 pathway in lupus nephritis.
    Chen J; Wei L; Xia Y
    Nephrology (Carlton); 2017 Feb; 22(2):101-106. PubMed ID: 27786399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered expression of TNFSF4 and TRAF2 mRNAs in peripheral blood mononuclear cells in patients with systemic lupus erythematosus: association with atherosclerotic symptoms and lupus nephritis.
    Rajabi P; Alaee M; Mousavizadeh K; Samadikuchaksaraei A
    Inflamm Res; 2012 Dec; 61(12):1347-54. PubMed ID: 22847298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.